Recursion Pharmaceuticals Summit Therapeutics: 2026 Insight
Two biotech contenders, Recursion Pharmaceuticals and Summit Therapeutics, face off in a year of uncertainty and oppo...
Searching for a credit card with no annual fee? Explore our top picks to save money and maximize your benefits without extra costs.
27,821 articlesTwo biotech contenders, Recursion Pharmaceuticals and Summit Therapeutics, face off in a year of uncertainty and oppo...
Two tech giants sit at the edge of a historic crown. This piece breaks down what would drive Apple about away from Nv...
Pi Network launches two major Pi App Studio updates to boost persistence and AI-driven planning, even as PI token hit...
German carmakers posted steep Q2 declines in China, with losses up to 41%. The drop highlights ongoing headwinds from...
When celebrities push extreme fitness, the real lesson isn’t just about looks—it’s about budgeting time, money, and r...
Chip stocks were crashing after a period of strong earnings, leaving many investors puzzled. This article unpacks why...
A quiet, strategic move by Warren Buffett's Berkshire Hathaway placed a small bet on The New York Times. Here’s what ...
Looking for growth you can ride for years? This guide breaks down three powerhouse names—NVIDIA, Microsoft, and Alpha...
Illinois and Hawaii join Wisconsin and Washington in tightening real estate listing rules, signaling a broader state-...
A major fund manager disclosed a sizable exit from a tactical commodity ETF, signaling a shift in market stance. This...
As earnings season arrives, methanex (meoh) 2025 earnings take center stage for investors watching methanol demand. T...
An insider stake moved when a Freshworks executive sold over 32,577 shares for roughly $275,000. This article breaks ...